---
title: AXOlabs vs Sinopep-Allsino Biopharmaceutical Co., Ltd.
slug_a: axolabs
slug_b: sinopep
site: cdmo
review_signal_gate: closed
canonical_path: /compare/axolabs/sinopep
generated_by: BioBM Editorial AI
---

# AXOlabs vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

AXOlabs (axolabs) is listed for both. Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.

Services: 13. Modalities: 1. Indications: 0. Locations: 3. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (13).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sinopep-Allsino Biopharmaceutical Co., Ltd. (sinopep) is listed for cdmo. GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.

Services: 6. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.